Researchers have created a bilayer metasurface made of two stacked layers of titanium dioxide nanostructures, opening new possibilities for structuring light.
Early clinical results suggest the firm's antibodies targeting the Vβ T-cell receptor could induce strong and durable responses in cancer patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback